Neurosoft Bioelectronics raised €6.5M in a Seed round in May 2026. The company is based in Zurich, Switzerland. Investors in the round: Connecticut Innovations, IAG Capital Partners, Protocol Labs and 1 other. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
